Orange Book product · Brand (NDA)
VOGELXO
TESTOSTERONE
At a glance
Jun 04, 2014
Approved
Brand (NDA)
Application
AB2
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 04, 2014
12 yr 3 mo ago
Today
Patent 8785426 expires
Listed drug product patent expiration.
Feb 11, 2034
in 7 yr 9 mo
Patent 9295675 expires
Listed drug product patent expiration.
Feb 11, 2034
in 7 yr 9 mo
Patent 9662340 expires
Listed drug product patent expiration.
Feb 11, 2034
in 7 yr 9 mo
Pharmaceutical detail
Active ingredient
TESTOSTERONE
Strength
50MG/5GM PACKET
Dosage form
GEL
Route
TRANSDERMAL
TE code
AB2
Application
NDA 204399
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2014NATESTOBrand (NDA)
NDA 205488 · ACERUS
- 2013TESTOSTERONEBrand (NDA)
NDA 203098 · PERRIGO ISRAEL
- 2012TESTOSTERONEBrand (NDA)
NDA 202763 · ANI PHARMS
- 2011ANDRODERMBrand (NDA)
NDA 020489 · ABBVIE
- 2011ANDROGELBrand (NDA)
NDA 022309 · BESINS HLTHCARE
- 2010FORTESTABrand (NDA)
NDA 021463 · ENDO OPERATIONS
- 2010AXIRONBrand (NDA)
NDA 022504 · ELI LILLY AND CO
- 2003ANDROGELBrand (NDA)
NDA 021015 · BESINS HLTHCARE
- 2003STRIANTBrand (NDA)
NDA 021543 · AUXILIUM PHARMS LLC
- 2002TESTIMBrand (NDA)
NDA 021454 · ENDO OPERATIONS
- 1997TESTODERM TTSBrand (NDA)
NDA 020791 · ALZA
- 1993TESTODERMBrand (NDA)
NDA 019762 · ALZA
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8785426 | Feb 11, 2034 | in 7 yr 9 mo | ProductU-1531 |
| 9295675 | Feb 11, 2034 | in 7 yr 9 mo | ProductU-1531 |
| 9662340 | Feb 11, 2034 | in 7 yr 9 mo | ProductU-1531 |
